These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27861544)

  • 1. The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
    Shiota T; Miyasato Y; Ohnishi K; Yamamoto-Ibusuki M; Yamamoto Y; Iwase H; Takeya M; Komohara Y
    PLoS One; 2016; 11(11):e0166680. PubMed ID: 27861544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma.
    Ohnishi K; Yamaguchi M; Erdenebaatar C; Saito F; Tashiro H; Katabuchi H; Takeya M; Komohara Y
    Cancer Sci; 2016 Jun; 107(6):846-52. PubMed ID: 26991548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma.
    Saito Y; Ohnishi K; Miyashita A; Nakahara S; Fujiwara Y; Horlad H; Motoshima T; Fukushima S; Jinnin M; Ihn H; Takeya M; Komohara Y
    Cancer Immunol Res; 2015 Dec; 3(12):1356-63. PubMed ID: 26297710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma.
    Ohnishi K; Komohara Y; Saito Y; Miyamoto Y; Watanabe M; Baba H; Takeya M
    Cancer Sci; 2013 Sep; 104(9):1237-44. PubMed ID: 23734742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.
    Asano T; Ohnishi K; Shiota T; Motoshima T; Sugiyama Y; Yatsuda J; Kamba T; Ishizaka K; Komohara Y
    Cancer Sci; 2018 May; 109(5):1723-1730. PubMed ID: 29520898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals the reduction of CD169
    Maeshima Y; Kataoka TR; Vandenbon A; Hirata M; Takeuchi Y; Suzuki Y; Fukui Y; Kawashima M; Takada M; Ibi Y; Haga H; Morita S; Toi M; Kawaoka S; Kawaguchi K
    EBioMedicine; 2024 Sep; 107():105271. PubMed ID: 39173531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer.
    Takeya H; Shiota T; Yagi T; Ohnishi K; Baba Y; Miyasato Y; Kiyozumi Y; Yoshida N; Takeya M; Baba H; Komohara Y
    Pathol Int; 2018 Dec; 68(12):685-693. PubMed ID: 30516869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses.
    Komohara Y; Ohnishi K; Takeya M
    Cancer Sci; 2017 Mar; 108(3):290-295. PubMed ID: 28002629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD169
    Tacconi C; Commerford CD; Dieterich LC; Schwager S; He Y; Ikenberg K; Friebel E; Becher B; Tugues S; Detmar M
    Cell Rep; 2021 Apr; 35(2):108993. PubMed ID: 33852863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of CD169
    Topf MC; Harshyne L; Tuluc M; Mardekian S; Vimawala S; Cognetti DM; Curry JM; Rodeck U; Luginbuhl A
    Otolaryngol Head Neck Surg; 2019 Jul; 161(1):67-73. PubMed ID: 30744470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced number of CD169
    Strömvall K; Sundkvist K; Ljungberg B; Halin Bergström S; Bergh A
    Prostate; 2017 Nov; 77(15):1468-1477. PubMed ID: 28880401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma.
    Zhang Y; Li JQ; Jiang ZZ; Li L; Wu Y; Zheng L
    J Pathol; 2016 Jun; 239(2):231-41. PubMed ID: 27174787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological significance of cytotoxic lymphocytes in breast cancer and draining lymph nodes].
    Wang HY; He JJ; Shi QF; Lai BC; Ding HY; Zheng J; Wang YL
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):384-8. PubMed ID: 19781344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-localization of CD169
    Björk Gunnarsdottir F; Auoja N; Bendahl PO; Rydén L; Fernö M; Leandersson K
    Oncoimmunology; 2020 Nov; 9(1):1848067. PubMed ID: 33299660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD169
    Saito Y; Fujiwara Y; Miyamoto Y; Ohnishi K; Nakashima Y; Tabata Y; Baba H; Komohara Y
    Cancer Med; 2023 May; 12(9):10199-10211. PubMed ID: 36846928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer cells promote CD169
    Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
    Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.
    Kawaguchi S; Kawahara K; Fujiwara Y; Ohnishi K; Pan C; Yano H; Hirosue A; Nagata M; Hirayama M; Sakata J; Nakashima H; Arita H; Yamana K; Gohara S; Nagao Y; Maeshiro M; Iwamoto A; Hirayama M; Yoshida R; Komohara Y; Nakayama H
    Cancer Immunol Immunother; 2022 Sep; 71(9):2127-2139. PubMed ID: 35044489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tumor-associated macrophages in breast carcinoma invasion and metastasis.
    Yang J; Li X; Liu X; Liu Y
    Int J Clin Exp Pathol; 2015; 8(6):6656-64. PubMed ID: 26261547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD169
    Camara A; Lavanant AC; Abe J; Desforges HL; Alexandre YO; Girardi E; Igamberdieva Z; Asano K; Tanaka M; Hehlgans T; Pfeffer K; Pfeffer S; Mueller SN; Stein JV; Mueller CG
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35031565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.